Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
36.50B | 34.98B | 35.13B | 34.26B | 32.72B | 34.33B | Gross Profit |
4.33B | 3.89B | 3.81B | 3.59B | 3.30B | 3.48B | EBIT |
1.86B | 1.56B | 1.51B | 1.46B | 1.16B | 1.30B | EBITDA |
5.93B | 5.58B | 5.59B | 5.68B | 5.57B | 5.77B | Net Income Common Stockholders |
1.42B | 1.15B | 1.23B | 1.09B | 915.00M | 1.11B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.60B | 6.51B | 6.93B | 5.20B | 4.43B | 2.92B | Total Assets |
42.73B | 41.09B | 36.80B | 35.65B | 35.42B | 33.30B | Total Debt |
6.30B | 7.50B | 6.73B | 6.92B | 7.29B | 6.93B | Net Debt |
1.20B | 988.00M | 270.00M | 2.09B | 3.20B | 4.39B | Total Liabilities |
17.10B | 16.08B | 14.21B | 14.24B | 14.72B | 14.06B | Stockholders Equity |
25.62B | 25.01B | 22.59B | 21.41B | 20.70B | 19.24B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.44B | 3.58B | 2.38B | 2.62B | 2.13B | Operating Cash Flow |
0.00 | 4.98B | 4.67B | 4.67B | 5.06B | 5.14B | Investing Cash Flow |
0.00 | -3.13B | -1.01B | -2.25B | -2.42B | -3.08B | Financing Cash Flow |
0.00 | -1.82B | -2.05B | -1.67B | -1.10B | -1.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥9.74B | 6.86 | 3.48% | 4.50% | 28.66% | ||
73 Outperform | ¥368.54B | 24.48 | 3.59% | 4.08% | 8.10% | 8.04% | |
73 Outperform | €293.21B | 11.57 | 9.89% | 3.40% | 5.80% | 26.91% | |
69 Neutral | €247.42B | 13.09 | 8.44% | 2.93% | 9.65% | 7.14% | |
64 Neutral | $686.92B | 34.97 | 3.21% | 2.14% | -1.99% | -62.81% | |
63 Neutral | ¥11.79B | 11.69 | 3.92% | 0.38% | 207.32% | ||
63 Neutral | $4.26B | 11.28 | 5.43% | 215.24% | 4.12% | -8.73% |